Tashkent, Uzbekistan (UzDaily.uz) — On 24 June 2025, Abdullah Azizov, Director of the Pharmaceutical Industry Development Agency of Uzbekistan, held a meeting with representatives of CCL Holdings, one of Pakistan’s leading pharmaceutical companies.
Founded in 1965, CCL Holdings is a market leader in healthcare, personal hygiene, and household products across developing countries. Today, the company operates in over 23 countries and employs more than 3,000 specialists. With a robust production base and strong research and development (R&D) capabilities, the company is committed to improving public health and building a sustainable future.
During the meeting, the Director of the Agency gave a presentation outlining the opportunities offered by the innovative Tashkent Pharma Park pharmaceutical science and production cluster, highlighting the favorable conditions established for foreign investors.
The parties discussed key issues related to the government procurement program, pharmaceutical industry regulations, and the national health insurance system and its impact on the development of the pharmaceutical sector in Uzbekistan.
Representatives of CCL Holdings expressed interest not only in the Uzbek market but also in broader opportunities across the Central Asian region. They emphasized their intention to conduct a thorough assessment of potential entry strategies into the region.
